Name: Danish pharma giant Novo Nordisk's C-suite execs land in China: What's next?
Uploaded: 2026-07-06T15:37:18+08:00
Duration: 4 min 36 s
Description: Danish pharmaceutical firm Novo Nordisk's top executives have begun a high-level visit in China in June. As more multinational firms double down on their investments in China's healthcare and innovation ecosystem, Novo Nordisk's journey reveals the huge

Language

RSS

Newsletters

Home

China

World

Politics

Business

Sci-Tech

Health

Opinions

Video

Live

Radio

World Asia-Pacific Middle East Europe Americas Africa

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

04:37

Danish pharmaceutical firm Novo Nordisk's top executives have begun a high-level visit in China in June. As more multinational firms double down on their investments in China's healthcare and innovation ecosystem, Novo Nordisk's journey reveals the huge opportunities within the country's "Healthy China" development blueprint.

CGTN's Xu Yi reports to unpack all key takeaways.

Open in CGTN APP for better experience

Search Trends